Shreya Sharma

Ms. Shreya Sharma


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AIArvind Iyer
Arvind Iyer
KGKrishan Gupta
Krishan Gupta
SSShreya Sharma
Shreya Sharma
KHKishore Hari
Kishore Hari
YLYi Fang Lee
Yi Fang Lee
Debarka SenguptaDebarka Sengupta
Debarka Sengupta
We collated publicly available single-cell expression profiles of circulating tumor cells (CTCs) and showed that CTCs across cancers lie on a near-perfect continuum of epithelial to mesenchymal (EMT) transition. Integrative analysis of CTC transcriptomes also highlighted the inverse gene expression pattern between PD-L1 and MHC, which is implicated in cancer immunotherapy. We used the CTCs expression profiles in tandem with publicly available peripheral blood mononuclear cell (PBMC) transcriptomes to train a classifier that accurately recognizes CTCs of diverse phenotype. Further, we used this classifier to validate circulating breast tumor cells captured using a newly developed microfluidic system for label-free enrichment of CTCs.

6 December 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
AIArvind Iyer
Arvind Iyer
KGKrishan Gupta
Krishan Gupta
SSShreya Sharma
Shreya Sharma
KHKishore Hari
Kishore Hari
YLYi Fang Lee
Yi Fang Lee
Debarka SenguptaDebarka Sengupta
Debarka Sengupta
We collated publicly available single-cell expression profiles of circulating tumor cells (CTCs) and showed that CTCs across cancers lie on a near-perfect continuum of epithelial to mesenchymal (EMT) transition. Integrative analysis of CTC transcriptomes also highlighted the inverse gene expression pattern between PD-L1 and MHC, which is implicated in cancer immunotherapy. We used the CTCs expression profiles in tandem with publicly available peripheral blood mononuclear cell (PBMC) transcriptomes to train a classifier that accurately recognizes CTCs of diverse phenotype. Further, we used this classifier to validate circulating breast tumor cells captured using a newly developed microfluidic systems for label-free enrichment of CTCs.